In the present study, bioactive lignans from Zanthoxylum armatum fruits have been investigated for their anti‐inflammatory properties and evaluated using dendritic cell‐based immunological assays and network pharmacology. The ethyl acetate fraction was subjected to bioassay‐guided fractionation, chromatography, and HPLC to isolate pure compounds, characterised by NMR, LC‐QTOF‐MS, and single‐crystal x‐ray diffraction. Biological activities were evaluated using DPPH/ABTS radical scavenging assays, albumin denaturation and haemolysis inhibition assays, and flow cytometric analysis of IL‐12p40/70 and CD80 expression in CpG‐stimulated MuTuDC1940 dendritic cells. Sesamin exhibited the strongest antioxidant activity, while sesamin and fargesin showed notable anti‐inflammatory effects. In CpG‐stimulated MuTuDC1940 cells, sesamin reduced the proportion of IL‐12‐positive cells from 63.85% in the CpG‐treated group to 52.67%, whereas fargesin (63.23%) showed little change and eudesmin (65.88%) showed a slight increase. Nevertheless, intracellular IL‐12 MFI was significantly reduced by eudesmin, sesamin, and fargesin compared with CpG stimulation ( p < 0.01), suggesting modulation of IL‐12 expression intensity rather than a uniform reduction in the IL‐12‐positive cell population. Network pharmacology, PPI, GO, and KEGG analyses indicated involvement of PI3K–Akt, NF‐κB, JAK–STAT, toll‐like receptor, Rap1, and VEGF signalling pathways. These findings suggest these compounds may serve as potential natural therapeutics for inflammatory and immune‐mediated diseases.